Clinical Trial Update: T-Cell Project: Epidemiologic Component

View source ↗

Summary

Update on the completion of the epidemiologic component of the National Cancer Institute's T-Cell Project studying Peripheral T-Cell Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Peripheral T-Cell Lymphoma | Status: COMPLETED